About SmartZyme
SmartZyme is a company based in Herzliya (Israel) founded in 2013. SmartZyme has raised $4 million across 2 funding rounds from investors including Orbimed and VI Ventures. SmartZyme offers products and services including Assay Kits, ELISA Kits, Biology Cells, and Peptides. SmartZyme operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Smartzyme Biopharma, Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Orbimed
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SmartZyme
SmartZyme offers a comprehensive portfolio of products and services, including Assay Kits, ELISA Kits, Biology Cells, and Peptides.
Kits for biological testing and analysis in laboratories.
Kits for detecting proteins and antibodies in research.
Products for cell biology and culture applications.
Reagents used in protein research and experiments.
Funding Insights of SmartZyme
SmartZyme has successfully raised a total of $4M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SmartZyme
SmartZyme has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orbimed and VI Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for SmartZyme
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SmartZyme
Investment portfolio details for SmartZyme
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SmartZyme
Detailed financials for SmartZyme
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Smartzyme Comparisons
Peer comparison for SmartZyme
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SmartZyme
SmartZyme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of SmartZyme
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Smartzyme
Complete news archive for SmartZyme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SmartZyme
SmartZyme was founded in 2013 and raised its 1st funding round 2 years after it was founded.
SmartZyme is headquartered in Herzliya, Israel. It is registered at Herzliya, Tel Aviv District, Israel.
SmartZyme is a funded company, having raised a total of $4M across 2 funding rounds to date.
SmartZyme was founded in 2013 in Herzliya Pituach, Israel, within the biotechnology sector. The Provolution platform is employed for protein design and engineering to create enzymes with targeted characteristics. Focus is placed on the diabetes market, where an enzyme for enhanced glucose catalysis in test strips and the Go Patch Go system for on-demand blood glucose monitoring are being developed.
SmartZyme's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
SmartZyme offers Assay Kits, ELISA Kits, Biology Cells, and Peptides.
SmartZyme has 2 investors. Key investors include Orbimed, and VI Ventures.